Press Releases Phastar Scoops Multiple Finalist Positions in 2025 Scrip Awards October 1st, 2025 3 minute read Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as fi...
Press Releases Phastar Appoints Industry Veteran Billy Amzal as Head of Strategic Consulting June 24th, 2025 2 minute read London, UK, and Durham (NC), US – June 24th, 2025: Phastar, a global specialist biometrics & data science Contrac...
Press Releases Phastar Secures Finalist Spot at 2025 Citeline Awards April 10th, 2025 3 minute read London, UK, and Durham (NC), US – April 10th, 2025: Phastar, a global specialist biometrics & data science Contra...
Events ISBS 2026 February 12th, 2026 1 minute read Phastar is excited to be presenting at the upcoming The 8th International Symposium on Biopharmaceutical Statistics, ...
Events OCT Nordics 2026 February 11th, 2026 1 minute read We’re excited to share that Sam Caley, Associate Director of Strategic Partnerships, will be attending Outsourc...
Events BayesPharma 2026 February 10th, 2026 1 minute read We are excited to be presenting at BayesPharma, 21-22 October in Leiden, Netherlands. Statistical Foundations of AI: ...
Webinars Smarter Confidence Intervals in Multicenter Trials: The BSVI Advantage October 12th, 2026 2 minute read Confidence intervals are an important component of clinical trial reporting, supporting the accurate and reliable int...
Webinars Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA September 28th, 2026 2 minute read Bayesian methods are increasingly being considered to support dose optimization, extrapolation, and adaptive designs ...
Webinars AI for Clinical Research Series – Prediction June 26th, 2026 1 minute read Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...
Case Studies Transforming Uncertainty into Statistical Confidence: Simulation-Driven Design for a First-in-Human Reproductive Therapeutic July 20th, 2026 1 minute read Designing a first-in-human study is challenging. Designing one for a novel reproductive therapy with limited prior da...
Case Studies Turning Complexity into Regulatory Confidence: Designing a Seamless Phase 2b/3 Strategy for FDA Engagement July 20th, 2026 1 minute read Accelerating clinical development requires more than speed, it demands a careful balance between innovation, scientif...
Case Studies Enabling First-in-Human Trial Success: Delivering an Innovative Bayesian Phase I/II Oncology Design July 20th, 2026 1 minute read Helping an Emerging Biotech Navigate Complex Clinical Development Preparing for a first-in-human clinical trial prese...
Articles & Interviews Why Real-Time Data Analytics Are Vital for the Next Evolution of Clinical Trials August 12th, 2026 2 minute read Christian Schmidt, Associate Director at Phastar, explores how real-time data (RTD) analytics is helping sponsors ove...
Articles & Interviews How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials July 6th, 2026 2 minute read Christian Schmidt, Associate Director at Phastar, explores how real-time data analytics is helping sponsors overcome ...
Articles & Interviews Why Predictive Analytics are Crucial for Effective EU-HTAR Implementation July 6th, 2026 2 minute read Billy Amzal, Head of Strategic Consulting at Phastar, examines the evolving EU Health Technology Assessment Regulatio...
Blogs How to Choose a Clinical Data Management CRO That Delivers Quality and Compliance October 9th, 2026 6 minute read Choosing a clinical data management CRO can feel challenging when many providers make similar claims about quality, c...
Blogs Women in Statistics at Phastar: Driving Innovation in Clinical Trials October 6th, 2026 11 minute read From unlocking new insights to making clinical developments more relevant to people across the world, advanced statis...
Blogs Progression Free Survival in Oncology Trials: Regulatory Expectations and the Critical Role of Sensitivity Analyses October 1st, 2026 8 minute read Progression-free survival (PFS) offers sponsors the opportunity to assess treatment benefit earlier than overall surv...
Publications Transforming Clinical Development Through Exploration, Automation, and Prediction with AI September 23rd, 2026 1 minute read Artificial intelligence is transforming how life sciences organizations generate evidence, design clinical trials, an...
Publications Building Effective Partnerships Between Biotechs and CROs to Advance Clinical Development July 21st, 2026 1 minute read The biotech industry is evolving rapidly, with emerging companies leading the charge in clinical development. As outs...
Publications Flexible Dose-Finding in Early-Phase Oncology Combination Studies Enabling Mid-Trial Dose Insertions to Improve Dose Recommendations April 2nd, 2026 1 minute read Early-phase oncology combination trials often assume the optimal dose is already included in the dosing gri...
